Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of Oral Nicotine Pouches in Nicotine Users
NCT07128329Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Nov 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Johns Hopkins University. Primary endpoints: Maximum Plasma Concentration for Nicotine at 6.5 hours, Area Under the Curve for Nicotine at 6.5 hours and 7 more. Started Nov 2025; status: recruiting.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT07128329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07128329.